RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Apollo Endosurgery Stock

Apollo Endosurgery EBIT 2024

Apollo Endosurgery EBIT

-26.05 M USD

Ticker

APEN

ISIN

US03767D1081

WKN

A2DJ26

In 2024, Apollo Endosurgery's EBIT was -26.05 M USD, a -12.05% increase from the -29.62 M USD EBIT recorded in the previous year.

The Apollo Endosurgery EBIT history

YEAREBIT (undefined USD)
2026e-27.64
2025e-27.67
2024e-26.05
2023e-29.62
2022-27.82
2021-19.2
2020-15.79
2019-29.12
2018-32.32
2017-22.44
2016-20.76
2015-16.68
2014-17.81
2013-7.59
2012-5.56
2011-3.71
2010-4.49
20091.8
2008-11.74
2007-15.48

Apollo Endosurgery Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Apollo Endosurgery, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Apollo Endosurgery from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Apollo Endosurgery’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Apollo Endosurgery. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Apollo Endosurgery’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Apollo Endosurgery’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Apollo Endosurgery’s growth potential.

Apollo Endosurgery Revenue, EBIT and net profit per share

DateApollo Endosurgery RevenueApollo Endosurgery EBITApollo Endosurgery Net Income
2026e131.47 M undefined-27.64 M undefined-42.34 M undefined
2025e184.47 M undefined-27.67 M undefined-37.27 M undefined
2024e111.2 M undefined-26.05 M undefined-34.92 M undefined
2023e91.02 M undefined-29.62 M undefined-40.45 M undefined
202276.86 M undefined-27.82 M undefined-39.84 M undefined
202162.99 M undefined-19.2 M undefined-24.68 M undefined
202042.05 M undefined-15.79 M undefined-22.61 M undefined
201950.71 M undefined-29.12 M undefined-27.43 M undefined
201860.85 M undefined-32.32 M undefined-45.79 M undefined
201764.31 M undefined-22.44 M undefined-27.29 M undefined
201664.65 M undefined-20.76 M undefined-41.17 M undefined
201567.79 M undefined-16.68 M undefined-36.38 M undefined
20145.08 M undefined-17.81 M undefined-16.56 M undefined
20137.99 M undefined-7.59 M undefined-6.56 M undefined
20126.69 M undefined-5.56 M undefined-2.75 M undefined
20119.39 M undefined-3.71 M undefined-3.11 M undefined
20107.84 M undefined-4.49 M undefined-4.6 M undefined
200911.91 M undefined1.8 M undefined3.98 M undefined
20082.86 M undefined-11.74 M undefined-11.46 M undefined
2007370,000 undefined-15.48 M undefined-15.09 M undefined

Apollo Endosurgery stock margins

The Apollo Endosurgery margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Apollo Endosurgery. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Apollo Endosurgery.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Apollo Endosurgery's sales revenue. A higher gross margin percentage indicates that the Apollo Endosurgery retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Apollo Endosurgery's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Apollo Endosurgery's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Apollo Endosurgery's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Apollo Endosurgery. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Apollo Endosurgery's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Apollo Endosurgery Margin History

Apollo Endosurgery Gross marginApollo Endosurgery Profit marginApollo Endosurgery EBIT marginApollo Endosurgery Profit margin
2026e55.2 %-21.02 %-32.21 %
2025e55.2 %-15 %-20.2 %
2024e55.2 %-23.43 %-31.4 %
2023e55.2 %-32.54 %-44.44 %
202255.2 %-36.2 %-51.84 %
202155.5 %-30.48 %-39.18 %
202052.89 %-37.55 %-53.77 %
201950.64 %-57.42 %-54.09 %
201854.54 %-53.11 %-75.25 %
201761.78 %-34.89 %-42.44 %
201660.94 %-32.11 %-63.68 %
201569.74 %-24.61 %-53.67 %
201455.2 %-350.59 %-325.98 %
201355.2 %-94.99 %-82.1 %
201255.2 %-83.11 %-41.11 %
201155.2 %-39.51 %-33.12 %
201055.2 %-57.27 %-58.67 %
200955.2 %15.11 %33.42 %
200855.2 %-410.49 %-400.7 %
200755.2 %-4,183.78 %-4,078.38 %

Apollo Endosurgery Aktienanalyse

What does Apollo Endosurgery do?

Apollo Endosurgery Inc is a medical technology company based in Austin, Texas that specializes in minimally invasive surgical technologies and products. It was founded in 2005 and has since become one of the leading providers of endoscopic instruments and systems. The business model of Apollo Endosurgery is based on the development and marketing of innovative products for minimally invasive surgery. The company focuses on three main areas: bariatric surgery, gastrointestinal surgery, and endoscopic surgery. The goal is to provide patients with minimally invasive solutions that are less invasive, safer, and more effective than traditional surgical methods. In the field of bariatric surgery, Apollo Endosurgery offers a wide range of products for the treatment of obese patients. This includes the bioabsorbable Orbera gastric balloon system, which provides a non-surgical alternative for weight reduction. It is introduced endoscopically into the stomach and can reduce the volume of the stomach, resulting in a faster feeling of satiety. The system needs to be removed after six months, but studies have shown that it can lead to significant weight loss. In the gastrointestinal surgery sector, Apollo Endosurgery offers the OverStitch system for endoscopic sutures. This system allows for the safe and easy performance of sutures in hard-to-reach areas of the GI tract without the need for open surgery. The system can be used for a variety of applications, including the treatment of fistulas and sealing leaks in the esophagus and intestine. Apollo Endosurgery's endoscopic surgery division focuses on the development of instruments and systems for endoscopic procedures. This includes the OverStitch system, as well as the Flex-Endoflex system for endoscopic procedures in the biliary system. These products enable safer and more effective procedures. Overall, Apollo Endosurgery has developed a wide range of products for minimally invasive surgery, offering doctors and patients a variety of treatment options. The company has also evolved through acquisitions, such as the acquisition of the biopolymer-based Orbera system by Apollo Endosurgery Inc. The company has a strong international presence, operating in Europe, Asia, and the USA, and has numerous partners in these regions. It has established close relationships with key clinics and physicians and is actively involved in researching and developing new technologies for minimally invasive surgery. In conclusion, Apollo Endosurgery Inc is a leading medical technology company focused on the development of innovative products for minimally invasive surgery. The company offers a wide range of products for bariatric, gastrointestinal, and endoscopic surgery and has strong relationships with key clinics and physicians. Apollo Endosurgery has a strong international presence and consistently works on researching and developing new technologies to provide minimally invasive solutions for patients worldwide. Apollo Endosurgery ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Apollo Endosurgery's EBIT

Apollo Endosurgery's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Apollo Endosurgery's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Apollo Endosurgery's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Apollo Endosurgery’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Apollo Endosurgery stock

How much did Apollo Endosurgery achieve in EBIT for the current year?

In the current year, Apollo Endosurgery has achieved an EBIT of -26.05 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Apollo Endosurgery.

How has the EBIT of Apollo Endosurgery developed in recent years?

The EBIT of Apollo Endosurgery has increased by -12.049% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Apollo Endosurgery?

The EBIT of Apollo Endosurgery is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Apollo Endosurgery pay?

Over the past 12 months, Apollo Endosurgery paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Apollo Endosurgery is expected to pay a dividend of 0 USD.

What is the dividend yield of Apollo Endosurgery?

The current dividend yield of Apollo Endosurgery is .

When does Apollo Endosurgery pay dividends?

Apollo Endosurgery pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Apollo Endosurgery?

Apollo Endosurgery paid dividends every year for the past 0 years.

What is the dividend of Apollo Endosurgery?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Apollo Endosurgery located?

Apollo Endosurgery is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apollo Endosurgery kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apollo Endosurgery from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Apollo Endosurgery pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Apollo Endosurgery in the year 2023?

In the year 2023, Apollo Endosurgery distributed 0 USD as dividends.

In which currency does Apollo Endosurgery pay out the dividend?

The dividends of Apollo Endosurgery are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Apollo Endosurgery

Our stock analysis for Apollo Endosurgery Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apollo Endosurgery Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.